Drug Trial Radar · NCT00704847
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)
Last checked: Nov 19, 2026Latest source record: Apr 24, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,030
Actual
Start
Jun 2008
Primary completion
May 2011
Study completion Jun 2011
Sponsor
- Lead sponsor
- Nordic Bioscience A/SIndustry
- Sponsor type
- Industry
- Collaborators
- Novartis
- First posted
- Jun 25, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 51 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this phase III study is to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Patients with Osteoarthritis of the Knee
Conditions
- Osteoarthritis
Interventions
Oral Salmon CalcitoninDrug
0.8mg SMC021, twice daily
Oral Salmon Calcitonin (Placebo)Drug
0.8mg Placebo, twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Joint Space Width (JSW) in the Medial Tibia-femoral Knee Joint in the Signal Knee Measured by X-ray Change From Baseline Over 24 MonthsTime frame: Change from baseline to 24 months
- Pain Subscore Change From Baseline Over 24 Months as Assessed by Western Ontario and McMaster Universities Arthritis (WOMAC) IndexTime frame: Change from baseline to 24 months
Locations
18 sites in 10 countries. Site status is shown where the registry gives one.
Achieve Clinical Research, LLC
Tuscaloosa, Alabama
Center for Healthy Aging
Sacramento, California
Northwestern Center for Clinical Research
Chicago, Illinois
Midwest Pharmaceutical Research
City of Saint Peters, Missouri
Thurston Arthritis Research Center
Chapel Hill, North Carolina
Rheumatology Clinical Research Unit
Beachwood, Ohio
Hospital Universitaire St. Luc, UCL 5390
Brussels, Belgium
Centre de Rhumatologie St-Louis
Sainte-Foy (Québec), Canada
CCBR Czech
Pardubice, Czechia
CCBR Aalborg
Aalborg, Denmark
CCBR Ballerup
Ballerup Municipality, Denmark
CCBR Vejle
Vejle, Denmark
CCBR Hong Kong
Hong Kong, Hong Kong
Centrum Osteoporozy i Chorób Kostno Stawowych, ul. Waryńskiego 6/2
Bialystok, Poland
CCBR Poland
Warsaw, Poland
CCBR Romania
Bucharest, Romania
Hospital Universitario de la Paz
Madrid, Spain
Little Common Surgery
Bexhill-on-Sea, East Sussex, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.